Soleno Therapeutics (SLNO) Operating Leases (2021 - 2026)
Soleno Therapeutics (SLNO) reported Operating Leases of $3.2 million for Q1 2026, up 35.54% year-over-year from $2.4 million in Q1 2025, and up 62.93% on a QoQ basis from $2.0 million in Q4 2025.
Soleno Therapeutics (SLNO) has 6 years of Operating Leases data on file, last reported at $3.2 million in Q1 2026.
- Quarterly Operating Leases rose 35.54% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (up 35.54% YoY) and the FY2025 annual result came in at $2.0 million, down 20.55% from the prior year.
- Operating Leases climbed to $3.2 million in Q1 2026 per SLNO's latest filing, from $2.0 million in the prior quarter.
- Across five years, Operating Leases topped out at $3.2 million in Q1 2026 and bottomed at $37000.0 in Q1 2024.
- The 5-year median for Operating Leases is $2.0 million (2025), against an average of $1.5 million.
- Peak annual rise in Operating Leases reached 6281.08% in 2025, while the deepest fall reached 20.55% in 2025.
- Tracing SLNO's Operating Leases over 5 years: stood at $79000.0 in 2022, then rose by 26.58% to $100000.0 in 2023, then soared by 2372.0% to $2.5 million in 2024, then retreated by 20.55% to $2.0 million in 2025, then surged by 62.93% to $3.2 million in 2026.
- Per Business Quant, the three latest SLNO Operating Leases figures stand at $3.2 million (Q1 2026), $2.0 million (Q4 2025), and $2.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.20 Mn |
| Dec 31, 2025 | 1.96 Mn |
| Sep 30, 2025 | 2.11 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 2.36 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Sep 30, 2024 | 2.58 Mn |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 214,000.00 |
| Jun 30, 2023 | 273,000.00 |
| Mar 31, 2022 | 79,000.00 |
| Dec 31, 2021 | 175,000.00 |
| Sep 30, 2021 | 274,000.00 |
| Jun 30, 2021 | 500,000.00 |